Thursday, December 07, 2017
Academic researchers, tech-savvy startups, Big Pharma and biotech, nonprofits, government institutes and public-private partnerships are investigating existing drugs/drug candidates for the treatment of new indications.
Friday, September 22, 2017
Contract service providers to the (bio)pharmaceutical industry must help their customers speed the development of new drugs while reducing costs.
Perfusion cell culture is not a new concept. It was first introduced in the early 1980’s as a means for improving the productivity of cell-culture processes, which at the time generally suffered from low titers and inefficiencies.
A patient recently diagnosed with a chronic illness is prescribed a
medication. The physician trusts this drug and, as a result, the patient
assumes that it will help him/her manage the condition. Though neither
party may give much thought to how ...
The presence of particulate matter in pharmaceutical products con-tinues to be one of the top reasons for recall. This year, 11 of the 54 safety alerts issued by the FDA were for the presence of particulates in drug and therapeutic biological ...
Wednesday, March 15, 2017
It can help in disease pattern analysis by bringing information together in new ways; it facilitates drug discovery by enabling advanced search capabilities for analyzing millions of publications, patents and clinical trial documents; it can also ...
Wednesday, March 15, 2017
WHY IS CULTURAL INTEGRATION
FOLLOWING A MERGER SO IMPORTANT
TO THE SUCCESS OF THE NEWLY
FORMED ENTITY?
Wednesday, February 01, 2017
There seems to be no avoiding it, single-use manufacturing is quickly becoming the norm. Or, as Graeme Proctor, Single-Use Product Manager, Parker Domnick Hunter, phrases it, “Single-use is now widely accepted and people are having to justify why ...
Sunday, November 20, 2016
As pharmaceutical manufacturing becomes increasingly globalized, with
companies engaging both contract development and manufacturing
organizations (CDMOs), as well as contract research organizations
(CROs) in multiple countries, contamination ...
All signs point to further healthy growth of
the pharmaceutical contract manufacturing
market in 2016. For the fourth year in a row,
respondents to Nice Insight’s annual survey
of outsourcing-facing pharmaceutical and
biotechnology executives ...